Innovative treatment for parasites affecting 1.5 billion people shows safety and superior efficacy in phase II-III trial
A novel drug combination of albendazole and ivermectin demonstrates superior efficacy in treating Trichuris trichiura and other soil-transmitted helminths. The treatment has shown safety in a phase II-III trial, potentially aiding endemic countries in meeting the WHO's Roadmap for Neglected Tropical Diseases.
SourceMundo Sano España·JournalThe Lancet Infectious Diseases·TypeRandomized controlled/clinical trial·DateJan 10, 2025